Submit Deal

OPTINOSE INC

HQ - Yardley, PA

Summary

Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose, and throat (ENT) and allergy specialists.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 254 M

Avg. Deal Size£ 254 M

Market Context

Senior Management

Ramy Mahmoud
CEO
Jonathan Neely
VP of Investor Relations and Business Development

Sort

19 Mar 2025|United States|Pharmaceuticals

Target: OPTINOSE INC

Bidder: PARATEK PHARMACEUTICALS

8 Service Providers

3 Target | 5 Bidder

16 Dealmakers

2 Target | 14 Bidder

£ 254 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy